BioLargo Reports Q2 2025 Operating and Financial Results

Significantly Advances Energy Technologies and Clyra Medical Technologies WESTMINSTER, CA / ACCESS Newswire / August 13, 2025 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, today announced that its Quarterly Report for the three and six months ended June 30, 2025. To view the […]

Jaxxon Privacy Violation Under Investigation by Levi & Korsinsky, LLP

NEW YORK CITY, NY / ACCESS Newswire / August 13, 2025 / Levi & Korsinsky, LLP is investigating potential claims on behalf of California residents who visited Jaxxon’s website at https://jaxxon.com/. Levi & Korsinsky, LLP’s investigation indicates that legally protected data may have been unlawfully intercepted during visits to Jaxxon’s website, particularly affecting users who

InventHelp Inventors Develop New Seat Accessory for a Rolling Carry-On Suitcase (LOS-341)

“We wanted to create a convenient way to ensure a seat is always available when traveling with carry-on luggage,” said one of two inventors, fromGlendora, Calif., “so we invented FRANKLY. Our practical three-piece design provides added comfort, and it helps you keep your luggage close by and safe.” https://mma.prnewswire.com/media/2099578/InventHelp_Logo_jpg_Logo.jpg The patent-pending invention provides an effective

A.D.A.M. Consumer Health Successfully Maintains URAC Certification; Reinforces Commitment to Quality and Excellence

A.D.A.M. Consumer Health (A.D.A.M.), part of the global Ebix Group, has successfully passed and maintained its URAC Health Content Provider Certification – a significant milestone underscoring the company's commitment to providing credible, high-quality, and trusted health information to consumers. https://mma.prnewswire.com/media/2749921/EBIX_INC_Logo.jpg A.D.A.M was one of the first organizations to receive URAC Health Website Accreditation in 2001.

TODAY: Press Conference Regarding Racially Charged Assault on Truck Drivers involved in Hurricane Helene Cleanup Efforts

Date of Incident: June 26, 2025Location of Incident: Two Banks Development Landfill, Haywood County, NC Press Conference Date: Wednesday, August 13, 2025Time: 2:00 p.m. EST. Location: Marriott City Center – Congressional Room500 Fayetteville StreetRaleigh, NC 27601 Also available via Google Meet at the following link:meet.google.com/kmu-obxp-sct Attorneys from Matheson & Associates, PLLC will hold a press

Global Axial Flux Motor Market Growth at 66.7% CAGR – Revolutionizing Electric Mobility & Industry | Valuates Reports

What is the Market Size of Axial Flux Motor Market? The global market for Axial Flux Motor was valued at USD 272 Million in the year 2024 and is projected to reach a revised size of USD 16379 Million by 2031, growing at aCAGR of 66.7% during the forecast period. https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-8K8112/Global_Axial_Flux_Motor_Market_Insights_Forecast?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=axial_flux_motor

Replimune (REPL) Faces Securities Class Action Following Stock’s Collapse Amid FDA’s Rejection of Melanoma Drug – Hagens Berman

(NASDAQ:REPL), SAN FRANCISCO, Aug. 13, 2025 (GLOBE NEWSWIRE) — A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 (D. Mass.), has been filed and seeks to represent investors who purchased or otherwise acquired Replimune (NADAQ: REPL) securities between November 22, 2024 and July 21, 2025. The lawsuit comes after

Replimune (REPL) Faces Securities Class Action Following Stock’s Collapse Amid FDA’s Rejection of Melanoma Drug – Hagens Berman

Replimune (REPL) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma Drug – Hagens Berman REPL Investors with Losses Encouraged to Contact Hagens Berman GlobeNewswire August 13, 2025 SAN FRANCISCO, Aug. 13, 2025 (GLOBE NEWSWIRE) — A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 (D.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. – PETS

(NASDAQ:PETS), NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether PetMed and certain of its officers and/or directors have

Scroll to Top